Aptose to Present at the 17th Annual Biotech in Europe Forum
September 19, 2017 08:02 ET
|
Aptose Biosciences Inc.
SAN DIEGO, and TORONTO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics that target the...
Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806
September 12, 2017 08:00 ET
|
Aptose Biosciences Inc.
SAN DIEGO and TORONTO and SEOUL, South Korea, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing...
Aptose Reports Results for the Second Quarter Ended June 30, 2017
August 08, 2017 16:05 ET
|
Aptose Biosciences Inc.
SAN DIEGO and TORONTO, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated...